Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
The Mounjaro® 5mg pen is the secondary dose level for patients continuing their treatment journey. Utilizing the active ingredient Tirzepatide, this dose is designed to build upon the metabolic foundation established during your first month of treatment.
Key Benefits:
Continuous Appetite Control: Mimics hormones that regulate appetite and fullness to help maintain a reduction in "food noise".
Proven Clinical Efficacy: Mounjaro has been shown in 72-week studies to help adults with obesity lose up to 25% of their body weight.
Precision Dosing: Delivered via the KwikPen® system for a simple, once-weekly subcutaneous injection.
Metabolic Progress: Helps the body stay satisfied with smaller portions as you move toward your weight loss goals.
Product Details:
Dose: 5mg.
Format: Pre-filled KwikPen® for subcutaneous use.
Administration: One injection every seven days.
The Mounjaro® 5mg pen is the secondary dose level for patients continuing their treatment journey. Utilizing the active ingredient Tirzepatide, this dose is designed to build upon the metabolic foundation established during your first month of treatment.
Key Benefits:
Continuous Appetite Control: Mimics hormones that regulate appetite and fullness to help maintain a reduction in "food noise".
Proven Clinical Efficacy: Mounjaro has been shown in 72-week studies to help adults with obesity lose up to 25% of their body weight.
Precision Dosing: Delivered via the KwikPen® system for a simple, once-weekly subcutaneous injection.
Metabolic Progress: Helps the body stay satisfied with smaller portions as you move toward your weight loss goals.
Product Details:
Dose: 5mg.
Format: Pre-filled KwikPen® for subcutaneous use.
Administration: One injection every seven days.